TY - JOUR
T1 - Hospice enrollment among cancer patients in Texas covered by Medicare managed care and traditional fee-for-service plans
T2 - a statewide population-based study
AU - Elting, Linda S.
AU - Liao, Kai Ping
AU - Giordano, Sharon H.
AU - Guadagnolo, B. Ashleigh
N1 - Funding Information:
Supported by a grant from the Cancer Prevention and Research Institute of Texas, “CERCIT: Comparative Effectiveness Research on Cancer in Texas” RP160674
Funding Information:
This research was supported by a grant from the Cancer Prevention Research Institute of Texas (RP160674). The funding source was uninvolved in the conduct of the research and the interpretation of results. The authors declare no conflicts of interest with the funder and none with other entities related to the research. The authors have full control of the data which were obtained under a Data Use Agreement from the Texas Cancer Registry and the Centers for Medicare and Medicaid Services. These data are confidential and cannot be shared. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Publisher Copyright:
© 2019, Springer-Verlag GmbH Germany, part of Springer Nature.
PY - 2020/7/1
Y1 - 2020/7/1
N2 - Purpose: Although rates of hospice use have increased over time, insurance plan- and racial/ethnic-based disparities in rates have been reported in the USA. We hypothesized that increased rates of hospice use would reduce or eliminate insurance plan-based disparities and that racial/ethnic disparities would be eliminated in managed care (MC) insurance plans. Methods: We studied the use of hospice care in the final 30 days of life among 40,184 elderly Texas Medicare beneficiaries who died from primary breast, colorectal, lung, pancreas, or prostate cancer between January 1, 2007 and December 31, 2013, using statewide Medicare claims linked to cancer registry data. Rates of hospice use were computed by race/ethnicity and insurance plan (MC or fee-for-service (FFS)). We used logistic regression to account for the impact of confounding factors. Results: Rates of hospice use increased significantly over time, from 68.9% in 2007 to 76.1% in 2013. By 2013, differences in hospice use rates between MC and FFS plans had been reduced from 10% to < 5%. However, after accounting for insurance plan and confounding factors, racial/ethnic minority beneficiaries’ hospice use was significantly lower than non-Hispanic white beneficiaries’ (p < 0.0001). This disparity was observed among both FFS and MC beneficiaries. Conclusions: Hospice use in the final 30 days of life has increased among elderly cancer patients in Texas, virtually eliminating the difference between FFS and MC insurance plans. Despite these positive trends, racial/ethnic-based disparities persist. These disparities are not explained by confounding factors. Future research should address social and behavioral influences on end-of-life decisions.
AB - Purpose: Although rates of hospice use have increased over time, insurance plan- and racial/ethnic-based disparities in rates have been reported in the USA. We hypothesized that increased rates of hospice use would reduce or eliminate insurance plan-based disparities and that racial/ethnic disparities would be eliminated in managed care (MC) insurance plans. Methods: We studied the use of hospice care in the final 30 days of life among 40,184 elderly Texas Medicare beneficiaries who died from primary breast, colorectal, lung, pancreas, or prostate cancer between January 1, 2007 and December 31, 2013, using statewide Medicare claims linked to cancer registry data. Rates of hospice use were computed by race/ethnicity and insurance plan (MC or fee-for-service (FFS)). We used logistic regression to account for the impact of confounding factors. Results: Rates of hospice use increased significantly over time, from 68.9% in 2007 to 76.1% in 2013. By 2013, differences in hospice use rates between MC and FFS plans had been reduced from 10% to < 5%. However, after accounting for insurance plan and confounding factors, racial/ethnic minority beneficiaries’ hospice use was significantly lower than non-Hispanic white beneficiaries’ (p < 0.0001). This disparity was observed among both FFS and MC beneficiaries. Conclusions: Hospice use in the final 30 days of life has increased among elderly cancer patients in Texas, virtually eliminating the difference between FFS and MC insurance plans. Despite these positive trends, racial/ethnic-based disparities persist. These disparities are not explained by confounding factors. Future research should address social and behavioral influences on end-of-life decisions.
KW - Disparities
KW - End-of-life care
KW - Hospice
KW - Insurance
UR - http://www.scopus.com/inward/record.url?scp=85075342290&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85075342290&partnerID=8YFLogxK
U2 - 10.1007/s00520-019-05142-z
DO - 10.1007/s00520-019-05142-z
M3 - Article
C2 - 31760519
AN - SCOPUS:85075342290
SN - 0941-4355
VL - 28
SP - 3351
EP - 3359
JO - Supportive Care in Cancer
JF - Supportive Care in Cancer
IS - 7
ER -